Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial-Reference-Cited by-同舟云学术

Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial

Published:2015-06 Issue:9986 Volume:385 Page:2502-2509
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Hézode Christophe,Asselah Tarik,Reddy K Rajender,Hassanein Tarek,Berenguer Marina,Fleischer-Stepniewska Katarzyna,Marcellin Patrick,Hall Coleen,Schnell Gretja,Pilot-Matias Tami,Mobashery Niloufar,Redman Rebecca,Vilchez Regis A,Pol Stanislas

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Estimating progression to cirrhosis in chronic hepatitis C virus infection;Freeman;Hepatology,2001

2. Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma;Abdel-Hamid;J Gen Virol,2007

3. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource;Smith;Hepatology,2014

4. Global epidemiology and genotype distribution of the hepatitis C virus infection;Gower;J Hepatol,2014

5. Ribavirin monotherapy for chronic hepatitis C;Brok;Cochrane Database Syst Rev,2009

Cited by 237 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C Elimination in Egypt: Story of Success;Pathogens;2024-08-12

2. Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir in Treating HCV Genotypes 1 and 4 in Patients with Advanced Chronic Kidney Disease;Journal of Pharmacy and Bioallied Sciences;2024-07

3. Chlorination of antiviral drug ribavirin: Kinetics, nontargeted identification, and concomitant toxicity evolution;Journal of Hazardous Materials;2024-04

4. Therapeutic Intervention of Serine Protease Inhibitors against Hepatitis C Virus;Current Medicinal Chemistry;2023-10-19

5. Real-World Therapeutic Outcomes of Direct-Acting Antiviral Regimens and Formidable Challenges;Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives;2023-01